title: Successful Treatment and Secondary Prevention of Venous Thrombosis Secondary to Behçet Disease with Rivaroxaban.
abstract: We here present the successful initial treatment and secondary prophylaxis of superficial venous thrombosis secondary to Behçet's disease by a novel anticoagulant drug, rivaroxaban (Xarelto®). To our knowledge, this is the first case of using an oral direct inhibitor of FXa in this setting. Our findings are promising; the outcome was favourable without any adverse effect noted. We propose that the patients with Behçet's disease and venous thrombosis might benefit from the advantages of the new anticoagulant drug.
authors.affiliation: Haemostasis and Thrombosis Unit, Division of Haematology, Haemophilia Clinic, Saint-Luc University Hospital, Avenue Hippocrate 10, 1200 Brussels, Belgium; Division of Haematology, University Hospital Centre Zagreb, Medical School of Zagreb, Kišpatićeva 12, 10000 Zagreb, Croatia.
authors.forename: Ana
authors.identifier: 0000-0003-3532-2336
authors.initials: A
authors.lastname: Boban
authors.affiliation: Haemostasis and Thrombosis Unit, Division of Haematology, Haemophilia Clinic, Saint-Luc University Hospital, Avenue Hippocrate 10, 1200 Brussels, Belgium.
authors.forename: Catherine
authors.initials: C
authors.lastname: Lambert
authors.affiliation: Haemostasis and Thrombosis Unit, Division of Haematology, Haemophilia Clinic, Saint-Luc University Hospital, Avenue Hippocrate 10, 1200 Brussels, Belgium.
authors.forename: Cedric
authors.initials: C
authors.lastname: Hermans